SanBio Co Ltd (SNBIF)
3.85
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
SanBio Research and Development Expense (Quarterly): 2.750M for Jan. 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 2.750M |
| October 31, 2023 | 2.273M |
| July 31, 2023 | 7.603M |
| April 30, 2023 | 7.869M |
| January 31, 2023 | 8.405M |
| October 31, 2022 | 9.611M |
| July 31, 2022 | 16.93M |
| April 30, 2022 | 11.44M |
| January 31, 2022 | 12.34M |
| October 31, 2021 | 11.66M |
| July 31, 2021 | 10.24M |
| April 30, 2021 | 10.46M |
| January 31, 2021 | 10.56M |
| October 31, 2020 | 11.13M |
| July 31, 2020 | 8.779M |
| April 30, 2020 | 7.904M |
| January 31, 2020 | 13.43M |
| October 31, 2019 | 7.914M |
| July 31, 2019 | 8.442M |
| Date | Value |
|---|---|
| April 30, 2019 | 9.868M |
| January 31, 2019 | 10.98M |
| October 31, 2018 | 7.399M |
| July 31, 2018 | 6.310M |
| April 30, 2018 | 9.073M |
| January 31, 2018 | 10.30M |
| October 31, 2017 | 8.975M |
| July 31, 2017 | 9.585M |
| April 30, 2017 | 8.289M |
| January 31, 2017 | 5.669M |
| October 31, 2016 | 4.611M |
| July 31, 2016 | 5.443M |
| April 30, 2016 | 3.260M |
| January 31, 2016 | 3.872M |
| October 31, 2015 | 4.482M |
| July 31, 2015 | 3.908M |
| April 30, 2015 | 1.723M |
| January 31, 2015 | 1.383M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
2.273M
Minimum
Oct 2023
16.93M
Maximum
Jul 2022
9.459M
Average
9.611M
Median
Oct 2022
Research and Development Expense (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 1.320B |
| Nxera Pharma Co Ltd | 21.31M |
| PeptiDream Inc | 4.654M |
| Healios KK | 4.602M |
| AnGes Inc | 6.546M |